Long-acting octreotide treatment causes a sustained decrease in ghrelin concentrations but does not affect weight, behaviour and appetite in subjects with Prader-Willi syndrome.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples